Intro
If the last post made the case that VLDL is the A1C of the liver, this post has to deal with the objection that almost every clinically trained reader is already thinking.
It goes something like this.
VLDL is calculated from triglycerides. Triglycerides are noisy. They swing with the last meal, the last drink, the last workout. So a number derived from triglycerides cannot possibly carry the kind of weight that A1C carries.
That objection has a real point inside it. And it has stopped this conversation from happening for forty years.
It is also wrong in a specific and fixable way.
---
The Dismissal Has a Real Origin
The standard lipid panel reports VLDL-C using the Friedewald equation. Friedewald assumes that VLDL-C can be estimated as triglycerides divided by five.
That assumption was a clever shortcut in 1972. It allowed clinicians to get a usable LDL-C number without having to measure every fraction directly. It worked well enough on average, in fasted patients, with triglycerides in a moderate range.
But the assumption is built on the same number - triglycerides - that clinicians have been trained to mistrust. So the criticism has always written itself. If the input is noisy, the output is noisy. If triglycerides are unreliable, calculated VLDL inherits the unreliability. The whole signal gets waved away at the bedside.
The dismissal is not unreasonable. It is just aimed at the wrong target.
---
The Problem Is the Equation, Not the Signal
Friedewald is wrong at high triglycerides. It is wrong at low triglycerides. It is wrong post-prandially. And it is wrong in insulin resistance.
That last one matters. Insulin resistance is precisely the state in which VLDL is most informative and it is precisely the state in which the equation we use to estimate VLDL fails the worst.
We have been reading the most important signal through the most distorted lens, and then blaming the signal for the distortion.
That is not a problem with VLDL. That is a problem with the math.
---
The Fix Has Been Sitting on the Lab Panel
Most modern lipid panels now report a directly measured LDL-C alongside the calculated value. That single change breaks the entire chain.
When LDL-C is measured directly, VLDL-C can be obtained by simple subtraction.
> Total cholesterol minus HDL-C minus direct LDL-C equals VLDL-C.
No Friedewald. No triglyceride conversion factor. No assumption that falls apart in the patients who need the information most.
The result is a clean VLDL-C number that does not carry the criticism that has been used to dismiss it for decades. The data is already on the panel. It is just being read through the wrong equation.
---
Why This Matters for the A1C Parallel
Part of what makes A1C clinically powerful is that it is measured, not estimated.
If A1C were calculated from a single fasting glucose multiplied by a conversion factor, no clinician would trust it. They would, correctly, point out that fasting glucose is variable and that estimating a long-term marker from a moment-in-time value is not a real measurement.
That is exactly what Friedewald-calculated VLDL is. An estimate of a fraction, derived from a variable input, presented as if it were the fraction itself.
Direct-LDL-derived VLDL-C is something different. It is a real number for a real fraction, available on a standard lab panel, with no equation in the way.
That moves VLDL closer to A1C not just as a metaphor, but as a method.
---
What This Series Is Actually Asking You to Do
Once the measurement objection is removed, the framing from the last post stops being a thought experiment and starts being something the reader can do on Monday morning.
Look at the lab panel. Find the directly measured LDL-C. Subtract it, along with HDL-C, from total cholesterol.
What is left is VLDL-C.
And what VLDL-C is telling you, the rest of this series will explain.